Novelix Pharmaceuticals Limited (BOM:536565)

Novelix Pharmaceuticals Statistics

Total Valuation

BOM:536565 has a market cap or net worth of INR 520.63 million. The enterprise value is 511.34 million.

Market Cap	520.63M
Enterprise Value	511.34M

Important Dates

The next estimated earnings date is Friday, August 8, 2025.

Earnings Date	Aug 8, 2025
Ex-Dividend Date	n/a

Share Statistics

BOM:536565 has 12.94 million shares outstanding. The number of shares has increased by 22.73% in one year.

Current Share Class	12.94M
Shares Outstanding	12.94M
Shares Change (YoY)	+22.73%
Shares Change (QoQ)	+1.14%
Owned by Insiders (%)	37.08%
Owned by Institutions (%)	1.93%
Float	2.13M

Valuation Ratios

The trailing PE ratio is 616.13.

PE Ratio	616.13
Forward PE	n/a
PS Ratio	1.69
PB Ratio	2.97
P/TBV Ratio	2.97
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	605.13
EV / Sales	1.66
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-3.71

Financial Position

The company has a current ratio of 2.79

Current Ratio	2.79
Quick Ratio	1.95
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 0.68% and return on invested capital (ROIC) is 0.62%.

Return on Equity (ROE)	0.68%
Return on Assets (ROA)	0.45%
Return on Invested Capital (ROIC)	0.62%
Return on Capital Employed (ROCE)	0.70%
Revenue Per Employee	38.42M
Profits Per Employee	105,625
Employee Count	8
Asset Turnover	1.78
Inventory Turnover	50.79

Taxes

In the past 12 months, BOM:536565 has paid 388,000 in taxes.

Income Tax	388,000
Effective Tax Rate	31.47%

Stock Price Statistics

The stock price has increased by +106.19% in the last 52 weeks. The beta is 0.32, so BOM:536565's price volatility has been lower than the market average.

Beta (5Y)	0.32
52-Week Price Change	+106.19%
50-Day Moving Average	36.58
200-Day Moving Average	19.33
Relative Strength Index (RSI)	48.74
Average Volume (20 Days)	15,542

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BOM:536565 had revenue of INR 307.34 million and earned 845,000 in profits. Earnings per share was 0.09.

Revenue	307.34M
Gross Profit	11.61M
Operating Income	1.23M
Pretax Income	1.23M
Net Income	845,000
EBITDA	1.61M
EBIT	1.23M
Earnings Per Share (EPS)	0.09

Balance Sheet

The company has 6.79 million in cash and n/a in debt, giving a net cash position of 6.79 million or 0.52 per share.

Cash & Cash Equivalents	6.79M
Total Debt	n/a
Net Cash	6.79M
Net Cash Per Share	0.52
Equity (Book Value)	175.39M
Book Value Per Share	17.59
Working Capital	172.66M

Cash Flow

In the last 12 months, operating cash flow was -136.85 million and capital expenditures -1.06 million, giving a free cash flow of -137.91 million.

Operating Cash Flow	-136.85M
Capital Expenditures	-1.06M
Free Cash Flow	-137.91M
FCF Per Share	-10.66

Margins

Gross margin is 3.78%, with operating and profit margins of 0.40% and 0.27%.

Gross Margin	3.78%
Operating Margin	0.40%
Pretax Margin	0.40%
Profit Margin	0.27%
EBITDA Margin	0.52%
EBIT Margin	0.40%
FCF Margin	n/a

Dividends & Yields

BOM:536565 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-22.73%
Shareholder Yield	n/a
Earnings Yield	0.16%
FCF Yield	-26.49%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

The last stock split was on October 4, 2010. It was a reverse split with a ratio of 0.1.

Last Split Date	Oct 4, 2010
Split Type	Reverse
Split Ratio	0.1

Scores

Altman Z-Score	n/a
Piotroski F-Score	3